Patents by Inventor Mahesh V. Patel

Mahesh V. Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5700799
    Abstract: A compound of structural Formula I: ##STR1## or pharmaceutically acceptable salts thereof wherein: each n is independently 1 to 3; Y is choosen from a-n as defined herein; wherein each occurrence of said C.sub.1-6 alkyl may be substituted with one or more F, Cl, Br, I, OR.sup.1, CO.sub.2 R.sup.1, CN, SR.sup.1, or R.sup.1 (where R.sup.1 is a hydrogen or C.sub.1-4 alkyl); X and Z are independently C.sub.1-6 alkyl, C.sub.3-12 cycloalkyl or hydrogen, or X and Z form a C.sub.0-3 bridging group, preferably X and Z are hydrogen; U, V and W are independently C.sub.1-6 alkyl, F, Cl, Br, hydrogen or a C.sub.1-6 alkyl substituted with one or more of F, Cl, Br or I, preferably U and V are F and W is hydrogen; R is hydrogen, C.sub.1-12 alkyl, C.sub.3-12 cycloalkyl, C.sub.1-6 alkoxy, C.sub.1-6 alkyl substituted with one or more F, Cl, Br, I or OH; and q is 0 to 4 inclusive.
    Type: Grant
    Filed: March 4, 1996
    Date of Patent: December 23, 1997
    Assignee: Pharmacia & Upjohn Company
    Inventors: Douglas K. Hutchinson, Michael R. Barbachyn, Steven J. Brickner, Ronald B. Gammill, Mahesh V. Patel
  • Patent number: 5571701
    Abstract: Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 C1.sub.2 N.sub.9 0.sub.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: November 5, 1996
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Suresh R. Nadkarni, Sugata Chatterjee, Mahesh V. Patel, Kalvanapuram R. Desikan, Erra K. S. Vijayakumar, Bimal N. Ganguli, Jurgen Blumbach, Hans-Wolfram Fehlhaber, Herbert Kogler
  • Patent number: 5547950
    Abstract: A compound of structural Formula I: ##STR1## or pharmaceutically acceptable salts thereof wherein: each n is independently 1 to 3; Y is chosen from a-n as defined herein; wherein each occurrence of said C.sub.1-6 alkyl may be substituted with one or more F, Cl, Br, I, OR.sup.1, CO.sub.2 R.sup.1, CN, SR.sup.1, or R.sup.1 (where R.sup.1 is a hydrogen or C.sub.1-4 alkyl); X and Z are independently C.sub.1-6 alkyl, C.sub.3-12 cycloalkyl or hydrogen, or X and Z form a C.sub.0-3 bridging group, preferably X and Z are hydrogen; U, V and W are independently C.sub.1-6 alkyl, F, Cl, Br, hydrogen or a C.sub.1-6 alkyl substituted with one or more of F, Cl, Br or I, preferably U and V are F and W is hydrogen; R is hydrogen, C.sub.1-12 alkyl, C.sub.3-12 cycloalkyl, C.sub.1-6 alkoxy, C.sub.1-6 alkyl substituted with one or more F, Cl, Br, I or OH; and q is 0 to 4 inclusive.
    Type: Grant
    Filed: October 31, 1994
    Date of Patent: August 20, 1996
    Assignee: The Upjohn Company
    Inventors: Douglas K. Hutchinson, Michael R. Barbachyn, Steven J. Brickner, Ronald B. Gammill, Mahesh V. Patel
  • Patent number: 5451570
    Abstract: Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 Cl.sub.2 N.sub.9 O.sub.24, is a novel Glycopeptide antibiotic and has the following structure (SEQ. ID. No.
    Type: Grant
    Filed: December 30, 1992
    Date of Patent: September 19, 1995
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Suresh R. Nadkarni, Sugata Chatterjee, Mahesh V. Patel, Kalvanapuram R. Desikan, Erra K. S. Vijayakumar, Bimal N. Ganguli, Jurgen Blumbach, Hans-Wolfram Fehlhaber, Herbert Kogler